Hecht, J.L.; Janikova, M.; Choudhury, R.; Liu, F.; Canesin, G.; Janovicova, L.; Csizmadia, E.; Jorgensen, E.M.; Esselen, K.M.; Celec, P.;
et al. Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer. Cancers 2022, 14, 2242.
https://doi.org/10.3390/cancers14092242
AMA Style
Hecht JL, Janikova M, Choudhury R, Liu F, Canesin G, Janovicova L, Csizmadia E, Jorgensen EM, Esselen KM, Celec P,
et al. Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer. Cancers. 2022; 14(9):2242.
https://doi.org/10.3390/cancers14092242
Chicago/Turabian Style
Hecht, Jonathan L., Monika Janikova, Reeham Choudhury, Fong Liu, Giacomo Canesin, Lubica Janovicova, Eva Csizmadia, Elisa M. Jorgensen, Katharine M. Esselen, Peter Celec,
and et al. 2022. "Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer" Cancers 14, no. 9: 2242.
https://doi.org/10.3390/cancers14092242
APA Style
Hecht, J. L., Janikova, M., Choudhury, R., Liu, F., Canesin, G., Janovicova, L., Csizmadia, E., Jorgensen, E. M., Esselen, K. M., Celec, P., Swanson, K. D., & Wegiel, B.
(2022). Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer. Cancers, 14(9), 2242.
https://doi.org/10.3390/cancers14092242